These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 33476813)
1. The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies. Ramponi G; Folci M; De Santis M; Damoiseaux JGMC; Selmi C; Brunetta E Autoimmun Rev; 2021 Mar; 20(3):102759. PubMed ID: 33476813 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Kim SM; Choi SY; Kim SY; Kim J Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis. Bornstein G; Ben-Zvi I; Furie N; Grossman C Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688 [TBL] [Abstract][Full Text] [Related]
4. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830 [TBL] [Abstract][Full Text] [Related]
5. Saint John on Patmos: Revelations of the Role of Antineutrophil Cytoplasmic Antibody (ANCA) in Vasculitis. Pijnappel EN; Rijkers GT; Overveld FJV Curr Med Chem; 2020; 27(17):2852-2862. PubMed ID: 31838986 [TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Csernok E; Lamprecht P; Gross WL Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
9. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813 [TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis. Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Harper L; Cockwell P; Adu D; Savage CO Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943 [TBL] [Abstract][Full Text] [Related]
12. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA; Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324 [TBL] [Abstract][Full Text] [Related]
13. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis. Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969 [TBL] [Abstract][Full Text] [Related]
15. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis]. Nakano H; Ozaki S Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457 [TBL] [Abstract][Full Text] [Related]
16. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis]. Zhang L; Shuai Z; Hu Z; Zhang M; Chen S Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012 [TBL] [Abstract][Full Text] [Related]